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Background: Health-related quality of life (HRQL) has become an increasingly important outcome parameter in
clinical trials and epidemiological research. HRQL scores are typically bounded at both ends of the scale and often
highly skewed. Several regression techniques have been proposed to model such data in cross-sectional studies,
however, methods applicable in longitudinal research are less well researched. This study examined the use of beta
regression models for analyzing longitudinal HRQL data using two empirical examples with distributional features
typically encountered in practice.
Methods: We used SF-6D utility data from a German older age cohort study and stroke-specific HRQL data from a
randomized controlled trial. We described the conceptual differences between mixed and marginal beta regression
models and compared both models to the commonly used linear mixed model in terms of overall fit and
predictive accuracy.
Results: At any measurement time, the beta distribution fitted the SF-6D utility data and stroke-specific HRQL data
better than the normal distribution. The mixed beta model showed better likelihood-based fit statistics than the
linear mixed model and respected the boundedness of the outcome variable. However, it tended to underestimate
the true mean at the upper part of the distribution. Adjusted group means from marginal beta model and linear
mixed model were nearly identical but differences could be observed with respect to standard errors.
Conclusions: Understanding the conceptual differences between mixed and marginal beta regression models is
important for their proper use in the analysis of longitudinal HRQL data. Beta regression fits the typical distribution
of HRQL data better than linear mixed models, however, if focus is on estimating group mean scores rather than
making individual predictions, the two methods might not differ substantially.
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Health-related quality of life (HRQL) has become an
increasingly important outcome parameter in clinical
trials and epidemiological research to support clinical
and policy decision making or to monitor population
health [1,2]. Treatment effects on HRQL and population
values are commonly estimated using regression techni-
ques, however, HRQL scores typically exhibit specific
properties that make the use of ordinary least square
(OLS) regression at least doubtful for such kind of
data [3,4]. In particular, they are continuous variables* Correspondence: matthias.hunger@helmholtz-muenchen.de
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reproduction in any medium, provided the orbounded at both ends of the distribution (e.g. at 0 and 1)
and are often highly skewed. As a consequence, several
alternative regression methods have been suggested such
as censored least absolute deviation models [5], Tobit
models [4,5] and median regression [5,6]. A regression
technique that is gaining increasing attention in the ana-
lysis of doubly bounded outcome measures is the beta
regression as introduced by Ferrari and Cribari-Neto [7].
Beta regression was first mainly used in economic and
psychological applications [8,9], but has recently also
been proposed to analyze generic HRQL [3,10]. In these
contributions, it was shown that beta regression can
have substantial advantages over OLS regression, espe-
cially in estimating covariate effects when the true incre-
mental effect is large [3]. However, they also revealedl Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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observations on the boundary points [10].
While several regression models have been suggested
to address the idiosyncrasies of HRQL data in a cross-
sectional design, research on longitudinal regression
models is less well developed. This is both surprising
and unfortunate given that change in HRQL over time is
often the primary interest in applied work. Currently,
longitudinal quality of life data are mostly analyzed using
change scores [11], repeated measures ANCOVA
[12,13], and linear mixed models (LMM) [14,15].
Beta regression has recently been expanded to deal
with longitudinal data by introducing a beta-distributed
generalized linear mixed model (GLMM) [16,17]. How-
ever, a more-in-depth-comparison with traditionally
employed methods, especially the LMM, is still lacking.
Also, to date no study has examined the applicability of
longitudinal beta regression models to analyze HRQL
scores over time.
An elaborate comparison between beta regression and
linear regression in a longitudinal design is not only im-
portant with respect to model fit and predictive ability.
It is also important to realize that in longitudinal models
with non-identity link such as beta regression, the inter-
pretation of parameter coefficients depends on how the
correlation between observations is accounted for [18].
Basically, two different approaches can be distinguished:
A subject-specific approach as implemented by the
GLMM, and a population-averaged approach using mar-
ginal models [19].
The purpose of this study was to examine the use of
beta regression methods to analyze longitudinal HRQL
data. We describe the conceptual differences between
mixed effect models and marginal models researchers
should be aware of when extending beta regression
to the longitudinal case. Using two empirical datasets
with both generic and disease-specific HRQL scores,
we compare estimated effects and predictive accuracy of




We fitted longitudinal regression models to two empir-
ical data sets representing different distributional features
typically encountered when analyzing HRQL scores in
practice. Data in the first example come from a cohort
study, while data in the second example were collected
alongside a randomized controlled trial (RCT). In both
cases, we examined HRQL scores over time with respect
to two groups of individuals.
In the first application, we examined how the generic
SF-6D health utility index changed over a 7-year period
in an older general population sample. Data come fromthe population-based KORA S4/F4 cohort study con-
ducted in the region of Augsburg in Southern Germany.
The sample used in our analyses involved 1225 subjects
aged 60 years and above recruited for the S4 survey in
1999. In 2006–2008, 812 of these 1225 subjects took
part in the follow-up study F4. A detailed description of
study design, sampling method and data collection can
be found elsewhere [10,20]. Besides other questions,
individuals were asked at both time points if they have
diabetes mellitus. Also, subjects answered the 12-item
Short-Form Health Survey (SF-12), from which the SF-
6D utility index was derived [21]. Health utilities can be
used to calculate quality-adjusted life-years (QALYs) and
usually range between 0 (health state similar to death)
and 1 (‘perfect health’). However, due to the specific
health state classification behind the SF-6D, possible
values only lie between 0.345 and 1 [21]. Focus in this
analyses was on the question how diabetes mellitus is
associated with HRQL over time.
The second application investigated disease-specific
HRQL in stroke patients over time, measured by the
Stroke Impact Scale (SIS) [22]. Data were collected
alongside an RCT evaluating a patient education
programme for stroke survivors in neurological rehabili-
tation based on the conceptual framework of the Inter-
national Classification of Functioning, Disability and
Health (ICF). The study sample comprised 212 patients
in the age range of 22 to 83 years recruited between
2008 and 2009 in seven rehabilitation clinics in Ger-
many. Details on clinical characteristics and data collec-
tion methods can be found elsewhere [23]. Patients
answered self-report questionnaires before and after the
education programme (median difference 10 days) as
well as at a postal follow-up conducted 6 months later.
At post-intervention and follow-up, questionnaire data
were available for 183, and 171 patients, respectively.
Patients in the sample were assigned to two different
rehabilitation phases (C and D), following the six-phase
model of the German Federal Rehabilitation Council.
The distinction between phase C and D contrasts
patients still dependent on a high degree of nursing and
medical care to those having mostly gained independ-
ence in the activities of daily life [24]. Since regaining
mobility is a major goal of post-stroke rehabilitation, the
objective of the analyses was to analyze SIS mobility sub-
scale (SIS-Mob) scores over time. SIS-Mob scores range
from 0 to 100, with higher values indicating better
HRQL. We divided scores by 100 in order to make them
fit to the support of the beta distribution. In this ana-
lysis, we focused on the comparison of time trends
between patients in phase D and those in phase C but
ignored whether patients were assigned to the interven-
tion or to the control group.
Both studies were approved by the local ethic committee.
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Beta regression for cross-sectional data
The beta distribution is a continuous probability distribu-
tion defined over the unit interval with density function
f y; μ;φð Þ ¼ Γ φð Þ
Γ μφð ÞΓ 1 μð Þφð Þ y
μφ1 1 yð Þ 1μð Þφ1;
0 < y < 1;
where Γ (.) denotes the gamma function [7]. The param-
eter μ denotes the expected value of Y, i.e. E(Y) = μ.
The parameter φ fulfils the definition of a precision
parameter since – for fixed μ – the greater the value
of φ, the smaller the variance of the dependent variable.
More specifically,
Var Yð Þ ¼ μ 1 μð Þ
1þ φ :
The beta distribution is part of the exponential family,
but not of canonical form [18,25]. In beta regression
models, the mean parameter μ 2 (0,1) of the beta distri-
bution is expressed as a function of covariates, while the
precision parameter φ 2 ℝ+ is treated as nuisance. To
map the linear predictor into the space of observed
values on the unit interval, the logit link
g μið Þ ¼ log
μi
1 μi
¼ xTi β; ð1Þ
is commonly used as the link of choice where xTi denotes
a vector of covariates, and β refers to the vector of re-
gression coefficients, i= 1,. . .,N [8,26]. The beta distribu-
tion is defined on the open unit interval only. If ones
and zeros are observed, these values need to be trans-
formed in order to fall into the open unit interval (0,1).
This can be achieved by either minimally compressing
the entire range of observed values, or by only trans-
forming the boundary points to slightly smaller or
greater values, respectively. The most frequently applied
transformation is given by
Y  ¼ Y N  1ð Þ þ 0:5½ =N ð2Þ
where Y* is the transformed and Y is the untransformed
dependent variable [8,17]. Alternatively, it has been sug-
gested to add a small amount E, e.g. 0.005 or 0.01 to the
lower bound, and to subtract the same amount from the
upper bound [8,16]. A reasonable choice involves the
following trade-off: On the one hand, large values for E
shrink the data more toward 0.5 and may bias the esti-
mates toward no effect; on the other hand, moving zero-
and one-valued observations an insufficient distance
away from the boundary may lead to instable estimates
because this can cause the likelihood to have a local or
even global mode in this area [16,27]. Hunger et al. alsoobserved that when the resulting values are too close to
the boundary points, precision of the estimates may
appreciably decrease [10]. Therefore, it has been recom-
mended to use sensitivity analyses in order to check
whether different endpoint handling methods affect par-
ameter estimates [8,16].
Beta GLMM for longitudinal data
In longitudinal analyses or in the case that subjects
are clustered within sampling units or geographical
entities, measurements within the same person or unit
are typically correlated, violating the assumption of
conditionally independent observations in regression
models [18]. One possibility to account for these de-
pendencies is to add random cluster or subject effects
into the linear predictor. Without loss of generalizability,
consider the case of longitudinal designs where j= 1,. . .,
ni observations are nested within i= 1,. . .,N subjects. Let
bi denote a vector of subject-specific random effects for
individual i.
In the linear regression model, the inclusion of
random effects leads to the LMM given by
Yij ¼ xTij βþ zTij bi þ Eij with bi  N 0;Gð Þ and Eij  N 0; σ2
 
ð3Þ
Similarly, adding random effects to the beta regression




¼ xTij βþ zTij bi with bi  N 0;Gð Þ: ð4Þ
In both cases, zTij is a vector of covariates, and G
denotes the positive definite covariance matrix of the
random effects. Note that although the assumption of
normality for the random effects is common and statisti-
cally convenient, other distribution assumptions are pos-
sible in principle [17]. In a longitudinal design, bi
typically is a scalar (for random intercept only models)
or a bivariate vector (for models with random intercept
and random slope). In the first case, zij= 1, while in the
second case, zTij ¼ 1; tij
 
; where tij is the time of meas-
urement j for subject i. Models with random slope
allow the linear effect of time to vary across subjects.
Model parameters are estimated by maximizing the mar-
ginal likelihood which is obtained by integrating out the
unobserved random effects bi from the likelihood func-
tion [16].
Although the inclusion of random effects in the beta
GLMM is conceptually the same as in the LMM, there
are important implications with regard to the inter-
pretation of regression parameters: In the LMM, the
fixed effects have both a subject-specific (together
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interpretation. This follows directly from (3) because
E Yijjbi
  ¼ xTij βþ zTij bi; and E Yij  ¼ xTij β:
In the beta GLMM, however, the regression para-
meters only have a subject-specific interpretation and no
longer describe the effect of the respective variable on
the population in general [18]. This is due to the non-
linear transformation of the mean response (i.e. the logit
link) since it can be deduced from (4) that
logit E Yijjbi
   ¼ xTij βþ zTij bi;
but logit E Yij
   6¼ xTij β:
This individual-specific interpretation means, for example,
that the parameter coefficient of the covariate ‘diabetes’
in the first empirical application refers to the difference
in mean SF-6D scores on the logit scale between an indi-
vidual with diabetes and the same individual supposed
not to have diabetes [28].
Beta GEE
If a population-averaged interpretation of the regression
coefficients is desired, for example the mean difference
between the groups of individuals with and without dia-
betes, an alternative to the beta GLMM is the marginal
model. The term ‘marginal’ means that the mean response
modeled is conditional only on covariates and not on
other responses or random effects [18].
Marginal models do not specify the full joint dis-
tribution of the data, but only specify a mean func-
tion, a variance function, and a correlation structure
between observations within one individual. Mean and
variance function (in some models together with an
additional scaling factor φ) are often suggested by
the canonical form of the exponential family [29].





ij β following (1), and using the variance
function Var Yijjxij
  ¼ φμij1 μij.
Note that this specification of mean and variance
structure is also commonly used in GEE models to
analyze binary data. The only difference is the additional
scaling parameter φ which is usually not used in a GEE
for binary data. The inclusion of the scaling parameter
in the beta GEE has no impact on the estimation of the
mean model parameters, however, it has the advantage
that large estimates for φ can indicate heterogeneity in
the data that is not accounted for by the model [3].
Similarities also exist to the inclusion of an additional
dispersion parameter in quasi-binomial models for
cross-sectional data and such methods have already been
used in literature to model HRQL scores [30-32]. For
the working correlation matrix, several choices arepossible. Among them, compound symmetry, autore-
gressive structure, and unstructured correlation are most
commonly used in longitudinal analyses [18]. Variance
function and correlation matrix can then be combined
into a ‘working’ covariance matrix Vi. Parameter esti-
mates in the marginal model are obtained by solving the
Generalized Estimating Equations (GEE) introduced by





i Yi  μið Þ ¼ 0
where Yi ¼ Yi1; . . . ;Yinið ÞT ; μi ¼ μi1; . . . ; μini
 T
; and
Di ¼ Di βð Þ ¼ @μi βð Þ=@βT .
In general, there are no closed-form solutions, so that
iterative algorithms are used. Specific types of GEEs
can further be distinguished according to how the
covariance parameters are estimated. While the early
contributions on GEEs mainly used the methods of
moments, other approaches using pseudo-likelihood tech-
niques and quadratic estimation equations methods have
also been suggested [35]. The latter approach, for example,
is implemented in the SAS GLIMMIX procedure. Param-
eter coefficients in the GEE are estimated consistently
even if the covariance structure is mis-specified, however,
a careful choice of the working correlation may improve
efficiency of the estimates. Valid standard errors for β^
can be calculated by using the so called sandwich estima-
tor [18]. Since the full likelihood of the data is not speci-
fied in GEE models, likelihood-based criteria to assess
model fit are not available.
Missing data
Missing data are an important issue in many quality of
life studies. Whether inference remains valid in the case
of incomplete data depends on the underlying missing
data mechanism and the statistical methods used. Esti-
mates from the beta GLMM remain valid if the data are
missing at random (MAR), i.e. that given the observed
data, the probability of a missing observation does not
depend on the unobserved data [36,37]. However, this
requires maximum likelihood estimation based on adap-
tive Gaussian quadrature to be used; other estimation
methods such as penalized quasi likelihood (PQL) can
lead to biased estimates of the covariate effects [18]. In
contrast, inferences with the beta GEE are only valid
under the stronger assumption that data are missing
completely at random (MCAR), i.e. that missingness is
independent of both, unobserved and observed data
[33,38]. Extensions of the GEE have been proposed
to allow the data to be MAR, however, these methods
either focus on monotone missing patterns or require
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matrix [39,40].
Model comparison and residuals: current state of research
Model comparison and model checking in the GLMM
and GEE framework is not straightforward and suitable
methods are sparse [41]. In general, if GLMMs are
estimated using a full likelihood approach, models can
be compared using information criteria such as Akaike
Information Criterion (AIC) or Bayesian Information
Criterion (BIC) [16]. AIC and BIC are measures of the
likelihood, penalized for the complexity of the model.
Zimprich suggested comparing beta GLMM and LMM
on the basis of a pseudo-R2 which is motivated from
the pseudo-R2 suggested by Cox and Snell for model
comparison in logistic regression models [17,42]. It is
defined as




where LIntercept is the likelihood of a simple intercept-
only linear model fit to the data, LFull is the likelihood of
the considered beta GLMM or LMM, and N is the total
number of observations. The pseudo-R2 compares the
likelihood of the observed data in the beta GLMM and
LMM with that of a simple intercept-only linear regres-
sion model. Thus, it reflects the improvement each
model has over a model without explanatory variables
and can be interpreted as the geometric mean squared
improvement per observation [42].
There are two types of residuals in the GLMM. De-
pending on the level on which fitted values are pro-
duced, one can distinguish average Pearson residuals
(related to the unconditional mean g1 xTij β
 
) and
individual-specific residuals (relating to the conditional
means g1 xTij βþ zTij bi
 
) where g denotes the link func-
tion of the regression model (i.e. the logit in the beta
GLMM). Diagnostic plots typically use individual-
specific residuals. Several different residuals have been
proposed for use in beta regression with independent
observations, namely standardized residuals, deviance
residuals, weighted residuals, and standardized weighted
residuals [7,43]. However, none of these residuals has
yet been extended to be applicable in the mixed regres-
sion context.
Basu and Manca used a beta regression model to
analyze QALY data and examined raw scale residuals
to evaluate goodness of fit [3]. In particular, they calcu-
lated mean residuals across deciles of the linear pre-
dictor in order to identify systematic patterns of misfit
in the predictions.Model specification
In both empirical examples, we compared the perform-
ance of LMM, beta GLMM, and beta GEE model.
Response variables were the SF-6D score and the SIS
mobility subscale (SIS-Mob) score, respectively.
We transformed the zero- and one-valued responses
in our empirical datasets to 0.005 and 0.995, respectively
[8,10,16]. This is because transformation (2) depends on
the number of observations, and its use in the large
KORA data would move the one-valued observations to
0.9997 which is extremely close to the upper bound.
However, to ensure that estimates are not affected by
this choice, we also used other values for E between
0.002 and 0.01 to move observations away from the
boundary points.
Covariates in the regression models were age at base-
line, sex, and time point. In the KORA data, we add-
itionally included diabetes and its interaction with time.




¼ β0 þ β1agei þ β2sexi þ β3timeij
þ β4diabij þ β5diabij  timeIIij þ bi;
where timeIIij is the dummy variable for the second
measurement time.
In the ICF stroke data, we additionally included reha-




¼ β0 þ β1agei þ β2sexi þ β3timeIIij
þ β4timeIIIij þ β5phaseDi þ β6phaseDi
 timeIIij þ β7phaseDi  timeIIIij þ bi
where timeIIij and timeIIIij are the dummy variables for
the second and third measurement times, respectively.
The same (fixed effects) covariate structure was specified
for the beta GEE models.
Since we only had two to three time points, our mixed
models only contained a random intercept but no ran-
dom slope component. In accordance, we chose a com-
pound symmetry correlation structure in the GEE
models, assuming that all measurements on the same
unit are equally correlated. In the case of two measure-
ments only, this structure is identical to more compli-
cated structures such as autoregressive correlation.
Taking an individual-specific perspective, we compared
model fit of LMM and beta GLMM using AIC, BIC, and
pseudo-R2. However, in contrast to Zimprich, we did not
calculate the pseudo-R2 by comparing the likelihood of
the models specified above to that of an intercept-only
linear model, but to the likelihood of a simple LMM
with random intercept only. This is because for longitu-
dinal data, the correlation between observations within
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basic model used for comparison.
To further examine whether the two models provide a
good fit to all parts of the data, we calculated mean raw
residuals on the individual-specific level across deciles of
the corresponding linear predictor [3]. If these means
are not randomly scattered around 0, this indicates a
systematic misfit of the model.
Taking the population average perspective, we com-
pared the unconditional predictions from the LMM with
the corresponding predictions from the marginal beta
GEE model. Fore each time point we calculated adjusted
mean HRQL scores stratified by diabetes (in the KORA
data) or rehabilitation phase (in the ICF stroke data).
If an individual had a missing quality of life score or
missing covariates at a certain time point, we deleted the
respective observation but did not exclude the entire in-
dividual from the analysis.
All models were estimated using the GLIMMIX pro-
cedure in SAS. We approximated the marginal likeli-
hood in the beta GLMM through Gaussian quadrature
which is implemented in the SAS GLIMMIX procedure
(from version 9.2) by the method = quad option. The
code used to fit LMM, beta GLMM and beta GEE to the
KORA data is provided in Additional file 1.
Results
In the KORA data, 91 observations were deleted due to
missing values in the response variable. One additional
observation was removed due to missing information on
the diabetes status. This reduced the final sample size
from 2037 to 1945. In the stroke data, the observations
from 15 participants were deleted because they had no
information on the rehabilitation phase. Nine further
observations were removed due to missing values in the
response variable. This reduced the final size from 566
to 517. In the KORA data, mean age at baseline was
66.2 years (SD 4.3), and 592 (50.9%) participants were
male. The percentage of individuals with diabetes was
8.9% at baseline and 16.2% at follow-up. Mean age in the
ICF stroke data was 57.2 years (SD 12.8), and 115
(54.3%) individuals were male. About two third (67.5%)
of the participants were assigned to rehabilitation phase
D, and one third to phase C.
When single density curves were fitted to the univari-
ate data, in both examples, the beta distribution repro-
duced the shape of the observed HRQL score (SF-6D
and SIS-Mob) distributions clearly better than the
normal distribution (Figure 1). It accommodated the
left-skew of the observed data and respected the
boundary points while large parts of the fitted normal
density function were lying outside the theoretically
possible range of HRQL values, especially in the ICF
stroke data.The parameter estimates of the regression analyses fit-
ted to the KORA data, are shown in Table 1. Comparing
LMM and beta GLMM, one observes that age, sex and
diabetes had a significant effect on the mean SF-6D util-
ity score in both models, however, with an AIC of −2723
and a BIC of −2682, the beta GLMM fitted the observed
data better than the LMM (AIC −2441; BIC −2401). This
is also reflected by the pseudo-R2 statistics. (0.054 in the
LMM, 0.181 in the beta GLMM).
Interpretation of parameter estimates in the beta
regression model is similar to logistic regression where
exponentiated coefficients can be interpreted in terms of
odds ratios. For example, the parameter coefficient of
male sex in the beta GLMM means that for a man, the
ratio between the expected quality of life score μ and
the difference to perfect health (1-μ) is about exp
(0.3483) = 1.42 times higher than for a woman with the
same set of covariates (and random effect).
The interaction between diabetes and time suggests
that the decline in HRQL over time was slightly larger in
individuals with diabetes, however, the interaction term
was only borderline significant.
Figure 2 shows the mean residuals across deciles of
the linear predictors for the KORA data. One observes a
strong correlation between residuals and predicted
means for both LMM and beta GLMM, suggesting that
both models overestimated the mean at the lower, and
underestimated the mean at the upper part of the distri-
bution. Probably, this results from the fact that generic
HRQL scores are usually highly dispersed and that we
only included very few covariates in our model.
Parameter coefficients from beta GLMM and beta
GEE are difficult to compare, however, one recognizes
that parameters in the GEE are estimated with less pre-
cision. The adjusted mean SF-6D scores from LMM and
beta GEE model together with their 95% confidence
intervals are shown in Table 2. It shows that both mod-
els produce very similar estimates but that for indivi-
duals with diabetes, standard errors from the LMM were
slightly smaller than those from the beta GEE.
The regression models fitted to the ICF stroke data are
shown in Table 3. Likewise, the table shows that the beta
GLMM fitted the data better than the corresponding
LMM. It achieved better AIC and BIC values and had
a higher pseudo-R2. Furthermore, the beta GLMM
respected the restricted range of the SIS-Mob scores,
whereas 6 individual predictions based on the LMM
estimates were lying outside the theoretically possible
range. The significant interaction term between time
and phase indicates that individuals in phase C showed
greater improvement over time than individuals in
phase D.
Looking at the mean residuals across deciles in
Figure 3, one recognizes that, compared to the LMM,
Figure 1 Distribution of SF-6D utility scores by time in the KORA data (upper part) and distribution of the SIS Mobility scores by time
in the ICF stroke data (lower part). The curves represent estimated single density functions of the beta (solid) and the normal (dashed)
distribution fitted to the univariate data.
Hunger et al. BMC Medical Research Methodology 2012, 12:144 Page 7 of 12
http://www.biomedcentral.com/1471-2288/12/144the beta GLMM underestimated the mean at the upper
part of the distribution.
The adjusted mean SIS-Mob scores from LMM and
beta GEE are shown in Table 4, suggesting that, again,
both methods lead to nearly identical mean estimates.
For patients in phase C, standard errors from the LMM
were smaller than those from the beta GEE model, how-
ever, the opposite was true for patients in phase D.
The use of different values E to move observations away
from the boundary points in the beta GLMM did not
appreciably affect parameter estimates; solely transform-
ation (2) decreased the precision of estimates by about 20%.
Discussion
Beta regression is a promising method for modeling
HRQL data in cross sectional research [3,10], and recent
methodological work has extended the beta regression
model to deal with dependent observations [8,16]. In
this paper, we examined the potential of beta regression
methods in the analysis of longitudinal HRQL data. We
highlighted the need to distinguish between mixed and
marginal models, namely beta GLMM and beta GEE,
when beta regression is extended to the longitudinalcase. Using two empirical applications with data distri-
butions typically encountered in practice, we compared
the performance of the beta regression methods to that
of the commonly used LMM.
Data collected in longitudinal designs typically have
correlated observations, violating a basic assumption of
ordinary regression methods. Longitudinal analyses re-
quire regression techniques that account for this de-
pendence. In general, the correlation among repeated
measures can be modeled implicitly, i.e. by including
random effects as in the mixed model, or explicitly, i.e.
by specifying a covariance structure between observa-
tions as in the marginal model. Through the inclusion of
random effects, mixed models assume natural hetero-
geneity across individuals in some regression coefficients
[18]. Random effects can also be motivated as an omit-
ted subject-varying covariate, thus they give a potential
explanation for the sources of correlation [19]. In con-
trast, marginal models treat the dependence between
observations as nuisance and account for its effects by
specifying a working correlation.
For linear longitudinal models, regression coefficients
have the same interpretation regardless of how the
Table 1 Parameter estimates of LMM, beta GLMM and beta GEE in the KORA data (N=1945)
Parameter coefficients LMM Beta GLMM Beta GEE
Estimate p value Estimate p value Estimate p value
Intercept 0.7808 <0.0001 1.3534 <0.0001 1.2816 <0.0001
Age at baseline (centered) −0.0036 <0.0001 −0.0185 0.0007 −0.0209 <0.0001
Male sex 0.0525 <0.0001 0.3483 <0.0001 0.3000 <0.0001
Time −0.0140 0.0002 −0.0788 0.0004 −0.0815 0.0002
Diabetes −0.0267 <0.0001 −0.1538 0.0002 −0.1586 <0.0001
Diabetes*Time −0.0300 0.0544 −0.1837 0.0608 −0.1513 0.0813
σ2 0.0091
φ 14.45
Variance of random effects Estimate SE Estimate SE Estimate SE
Variance 0.0095 0.0007 0.3854 0.0309
Covariance estimates
Variance 0.0536 0.0028
Compound symmetry 0.0564 0.0042
Scale 0.0240
Fit statistics
−2LogL −2457 −2739 -
AIC −2441 −2723 -
BIC −2401 −2682 -
Pseudo-R2† 0.0535 0.1812 -
LMM Linear mixed model, GLMM Generalized linear mixed model, GEE Generalized estimating equations, SE Standard error, CS Compound Symmetry, AIC Akaike
information criterion. BIC Bayesian information criterion.
†Compared to linear random-intercept model with -2LogL =−2350.
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http://www.biomedcentral.com/1471-2288/12/144correlation is modeled. For regression models with non-
identity link such as beta regression, however, interpret-
ation depends on whether a mixed model (i.e. a GLMM)
or a marginal model is fitted. In the GLMM, estimated
effects are adjusted for individual difference and thus
only refer to within-individual change. In the marginal
model, in contrast, the mean response is conditional
only on covariates and not on other responses or ran-
dom effects [18].Figure 2 Mean residuals across deciles of linear predictors for beta GThe choice between the two depends mainly on the
specific scientific question of interest. GLMMs are most
useful for making inferences about individuals and track-
ing individual trajectories, while the marginal model is
more useful for inferences about population or sub-
population averages. No model is a priori more suitable
for the analysis of HRQL data than the other. It has been
argued that mixed models may be more appropriate in
epidemiological research as they allow a betterLMM and LMM in the KORA data.
Table 2 Adjusted marginal mean SF-6D scores with 95%
confidence intervals for time and diabetes in the KORA
data (N= 1945)
Time T1 T2
Diabetes LMM 0.757 (0.732 – 0.782) 0.713 (0.692 – 0.735)
Beta GEE 0.758 (0.729 – 0.784) 0.712 (0.689 – 0.735)
No diabetes LMM 0.784 (0.776 – 0.792) 0.770 (0.760 – 0.780)
Beta GEE 0.786 (0.778 – 0.794) 0.772 (0.761 – 0.781)
Effects of age and sex are set equal to their mean values.
LMM Linear mixed model, GEE Generalized estimating equations.
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http://www.biomedcentral.com/1471-2288/12/144understanding of the underlying mechanisms [28]. Also,
they have a close relationship to matched-pair design
methods often used in epidemiologic and public health
research [19]. Due to the individual-specific interpret-
ation of regression coefficients, the GLMM is also most
meaningful for time-varying covariates. In contrast, the
interpretation of time-invariant or between-subject cov-
ariates in the GLMM is less intuitive or even misleading
since they also only allow a within-subject interpretation




Age (centered) −0.0031 0.0060
Male sex 0.0528 0.0599
Time 2 0.0801 0.0003
Time 3 0.1597 <0.0001
Phase D 0.2941 <0.0001
Phase D*Time2 −0.0463 0.0807
Phase D*Time 3 −0.1178 <0.0001
σ2 0.0126
φ











LMM Linear mixed model, GLMM Generalized linear mixed model, GEE Generalized
information criterion, BIC Bayesian information criterion.
†Compared to linear random-intercept model with -2LogL =−262.8.GLMM is used to estimate treatment effects on HRQL
in clinical trials, the respective treatment arm coefficient
is interpreted as the difference in outcomes between two
individuals with the same covariate values and the same
random effects bi, differing only in their treatment arm.
It does not describe the average treatment effect which is
usually of major interest in intervention studies, espe-
cially if preference-based HRQL measures are used in
economic evaluation studies [4]. Therefore, the marginal
model may be more suitable in many applications in
public health research. Also, it has been argued that
many epidemiologic methods such as stratified methods
are essentially population-averaged methods [19]. For
our empirical applications this means that the change in
SF-6D index scores associated with diabetes in the
KORA data may be better described by a beta GLMM,
while the difference in mean SIS scores between rehabili-
tation phases in the ICF stroke data may be better
assessed using a beta GEE. Differences between beta
GLMM and beta GEE also exist with respect to the
handling of missing data: In practice, the beta GLMM
may be more convenient since it remains valid under theEE in the ICF stroke data (N= 517)
Beta GLMM Beta GEE
Estimate p value Estimate p value
−0.0106 0.9569 −0.0766 0.6828
−0.0226 0.0015 −0.0162 0.0137
0.2931 0.0991 0.3200 0.0574
0.4637 0.0005 0.3343 0.0010
0.9254 <0.0001 0.6792 <0.0001
1.6160 <0.0001 1.4316 <0.0001
−0.2005 0.2240 −0.0832 0.5154
−0.5465 0.0017 −0.3573 0.0477
10.80









estimating equations, SE Standard error, CS Compound Symmetry, AIC Akaike
Figure 3 Mean residuals across deciles of linear predictors for beta GLMM and LMM in the ICF stroke data.
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http://www.biomedcentral.com/1471-2288/12/144MAR assumption which is usually more plausible in
quality of life studies than the MCAR assumption made
by the beta GEE.
A common approach to compare regression models
and assess goodness of fit is to consider likelihood-based
statistics which evaluate the probability of the observed
data under the model. In both of our empirical exam-
ples, beta GLMM had better fit statistics (such as AIC,
BIC or pseudo-R2) than the commonly used LMM, indi-
cating that the beta distribution better accounted for the
bounded support of the observed HRQL scores and their
highly skewed distributions. However, an important
question is whether better likelihood statistics make the
beta GLMM more suitable than the LMM in practice. A
similar issue has also been addressed previously: Zim-
prich used a beta GLMM to analyze longitudinal data on
complex choice reaction time and concluded from better
likelihood-based fit statistics that beta GLMM fitted the
data much better than a LMM did [17]. However, given
a fairly close similarity between parameter estimates, he
also raised the question whether apart from these statis-
tical considerations, beta GLMM is worth the effort to
apply in practical data analyses. We even go one step
further arguing that the likelihood may not be the most
relevant criterion when comparing models to analyze
HRQL data. Distributional fit and predicted densities
may be important in applications with focus on individ-
ual density forecasts, such as in the reaction time
example. However, when analyzing HRQL data in RCTsTable 4 Adjusted marginal mean SIS-Mob scores with 95% co
the ICF stroke data (N=517)
Time T1
Phase C LMM 0.521 (0.468 – 0.574)
Beta GEE 0.520 (0.440 – 0.600)
Phase D LMM 0.815 (0.779 – 0.852
Beta GEE 0.819 (0.787 – 0.847)
Effects of age and sex are set equal to their mean values.
LMM Linear mixed model, GEE Generalized estimating equations.or cohort studies, conditional means rather than predict-
ive densities are commonly of major interest [4]. Against
this background, more attention should be attached to
the question whether the mean structure is appropriately
reproduced by the model. Figure 2 showed that the beta
GLMM reproduced the observed values at the upper
end of the distribution less satisfactorily than the LMM.
This may be explained by the fact that beta regression
fits both means and variances to the data. Since in
the beta distribution the variance is a function of the
mean, the estimated mean function may be biased.
This phenomenon has already been observed in a cross-
sectional design and suggests that full likelihood-based
beta regression methods should be used with care when
analyzing HRQL [3].
In the marginal perspective, beta GEE produced nearly
identical estimates to the LMM, however, differences
could be observed with respect to standard errors, espe-
cially in the ICF stroke data (Table 4). The larger stand-
ard errors of the beta GEE for patients in phase C are
probably due to the fact that beta GEE provides robust
standard errors using the sandwich formula. The smaller
standard errors for patients in phase D, however, indi-
cate that beta regression accounts for heteroscedasticity
related to the bounded nature of the response variable
[8]. This is because the predicted means of individuals in
phase D were rather high, and for outcomes bounded on
the unit interval, the variability of scores declines as the
mean approaches one.nfidence intervals for time and rehabilitation phase in
T2 T3
0.601 (0.545 – 0.657) 0.681 (0.624 – 0.737)
0.602 (0.526 – 0.673) 0.681 (0.604 – 0.749)
0.849 (0.812 – 0.886) 0.857 (0.812 – 0.886)
0.853 (0.824 – 0.878) 0.862 (0.829 – 0.889)
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http://www.biomedcentral.com/1471-2288/12/144An important limitation of the beta regression is that
it does not contain the boundary points 0 and 1 so that
quite arbitrary transformation methods need to be
applied. However, our sensitivity analyses support previ-
ous research in that parameter estimates are robust to
the choice of transformation, provided that the values
are moved far enough away from the boundaries.
The two empirical data sets used in this study were
chosen to cover different types of studies commonly
encountered in HRQL research. In particular, we addressed
both disease-specific and generic HRQL scores and used
data both from a cohort study and from a clinical setting.
The two illustrative examples tackle clinically relevant
research questions that have also been addressed in other
studies [44-46]. However, since this paper focused on the
comparison between different methodological approaches,
we did not deal in detail with interpreting results in the
healthcare context. For the purpose of this paper we have
also made some simplifications, e.g. we did not consider
model building but preferred using a rather lean model
with only a few covariates. Also, we treated the precision
parameter in the beta GLMM as constant instead of mod-
eling it in terms of covariates, although such an approach
may have improved model fit [10,17,26].
Another limitation of our study is that our empirical
data only provided up to three measurements per indi-
vidual. Further research is needed to examine the use of
beta regression in more complex study designs. Also, we
did not consider random slopes which are commonly
used to model heterogeneity in the effect of time on the
response variable [15]. However, for reasons of model
convergence, it is not recommended to fit anything more
complex than a single random intercept model to non-
normal data with only a few time points per person.
Similarly, we did not consider working correlation struc-
tures other than compound symmetry in the beta GEE.
However, compound symmetry assumes the same cor-
relation for all observations within a person which we
think is reasonable in the case of only a few time points
per person. Furthermore, it corresponds to the correl-
ation structure implicitly modeled by the mixed model
with single random intercept.
Conclusions
In conclusion, longitudinal beta regression models are a
natural candidate to analyze HRQL over time since they
account for the bounded range and the skewed distribu-
tion of the response variable. However, depending on
whether a population-averaged or a subject-specific ap-
proach is preferred, researchers should distinguish be-
tween a mixed (beta GLMM) and a marginal (beta GEE)
model. The mixed model may be more appropriate
in cohort studies in order to track individual HRQL
trajectories, while the marginal model is more suitableto estimate average treatment effects in intervention
studies. Although beta regression addresses the specific
idiosyncrasies of bounded HRQL data, empirical esti-
mates only slightly differed from those of the commonly
applied linear mixed model.Additional file
Additional file 1: SAS Code used to fit LMM, beta GLMM and beta
GEE to the KORA data.
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